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Abstract
Objective.	To	determine	whether	disease	predicts	weight	
loss	 in	population-based	studies,	as	this	may	confound	the	
relationship	between	weight	and	mortality.	Materials and 
methods.	We	used	longitudinal	data	from	the	Costa	Rican	
Longevity	and	Healthy	Aging	Study	(CRELES)	and	the	English	
Longitudinal	Study	of	Ageing	(ELSA).	We	defined	two	overlap-
ping	outcomes	of	measured	weight	loss	between	waves:	>1.0	
point	of	body	mass	index	(BMI)	and	>2.0	BMI	points.	Logistic	
regression	models	estimated	the	associations	with	disease,	
adjusting	for	age	(range	52-79),	sex,	smoking,	and	initial	BMI.	
Results.	In	ELSA,	onset	of	diabetes,	cancer,	or	lung	disease	
is	 associated	with	 loss	>2.0	points	 (respectively,	OR=2.25	
[95%CI:	1.34-3.80];	OR=2.70	[95%CI:	1.49-4.89];	OR=1.82	
[95%CI:	 1.02-3.26]).	 In	CRELES,	 disease-onset	 reports	 are	
not	associated	with	weight	loss	at	5%	significance,	but	sta-
tistical	power	to	detect	associations	is	poor.	Conclusion. 
Although	it	is	known	that	some	diseases	cause	weight	loss,	
at	the	population	level	these	associations	vary	considerably	
across	samples.	
Key	words:	weight	loss;	body	weight	changes;	body	mass	index;	
diabetes	mellitus;	Costa	Rica;	England
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Resumen
Objetivo.	Determinar	si	las	enfermedades	predicen	pérdida	
de	peso	a	partir	de	encuestas	poblacionales,	debido	a	que	
esto	podría	confundir	 la	relación	entre	peso	y	mortalidad.	
Material y métodos.	Se	utilizaron	datos	longitudinales	
de	Costa	Rica:	Estudio	de	Longevidad	y	Envejecimiento	Sa-
ludable	(CRELES)	y	Estudio	Longitudinal	de	Envejecimiento	
en	Inglaterra	(ELSA,	por	sus	siglas	en	inglés).	Se	definieron	
dos	indicadores	de	resultado	no	excluyentes	de	pérdida	de	
peso	entre	rondas:	>1.0	punto	de	índice	de	masa	corporal	
(IMC)	y	>2.0	puntos	de	IMC.	Las	asociaciones	de	interés	se	
estimaron	con	modelos	de	regresión	logística,	con	controles	
para	la	edad	(rango	52-79),	sexo,	tabaquismo	actual	e	IMC	
inicial. Resultados.	En	el	ELSA,	 la	 incidencia	de	diabetes,	
cáncer	o	enfermedad	pulmonar	está	asociada	con	pérdida	
de	>2.0	puntos	de	IMC	(respectivamente:	OR=2.25	[IC95%:	
1.34-3.80];	OR=2.70	 [IC95%:	 1.49-4.89];	OR=1.82	 [IC95%:	
1.02-3.26]).	 En	 el	CRELES,	 el	 reporte	 de	 diagnóstico	 de	
enfermedades	no	muestra	asociación	significativa	a	5%	con	
pérdida	de	peso,	pero	el	poder	estadístico	de	la	muestra	para	
detectar asociaciones es limitado. Conclusión.	Aunque	es	
conocido	que	ciertas	enfermedades	causan	pérdida	de	peso,	
estas	asociaciones	a	nivel	poblacional	varían	considerable-
mente entre encuestas.
Palabras	clave: pérdida	de	peso;	cambios	en	el	peso	corpo-
ral;	 índice	de	masa	corporal;	diabetes	mellitus;	Costa	Rica;	
Inglaterra
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This study tests whether disease predicts weight loss among middle-aged and older adults who par-
ticipate in multiple waves of longitudinal, population-
based surveys. There are two major motivations for 
this research. First, previous studies find an association 
between weight loss and subsequent mortality in such 
longitudinal surveys.1-3 If disease does predict weight 
loss, this could explain the link between weight loss 
and mortality even though, for many individuals, mild 
to moderate weight loss is recommended to manage 
hypertension,4 diabetes,5 and other cardiovascular risk 
factors.6 Second, the relationship between disease and 
weight loss in population-based surveys is central to 
interpreting many epidemiological studies that analyze 
impacts of body weight on mortality risk.7 In those 
studies, body weight measures are typically assumed 
to reflect some combination of nutrition, fitness, and 
overall metabolic health. However, if weight also reflects 
disease processes, it is not straightforward to treat body 
weight as a causal exposure. Instead, body weight is 
both cause and effect of health outcomes. In short, the 
relationship between disease and weight loss matters for 
interpreting body weight and body mass index (BMI) 
intelligently in epidemiological research. 
 There is no good evidence about the population-
level association between disease and weight loss. 
Clinicians consider weight loss a symptom of many 
life-threatening conditions, including cancer, lung 
disease, and congestive heart failure,8 and disease is a 
demonstrated cause of weight loss in select clinical popu-
lations.9,10 Nevertheless, it is unclear whether disease 
drives weight loss in non-clinical samples, in which life-
threatening illness is probably rare. Two retrospective 
studies in the USA linked unintentional weight loss to 
poor health,11,12 but the results have not been replicated 
in prospective data. In contrast, using the longitudinal 
Americans’ Changing Lives Survey, Kahng, Dunkle, and 
Jackson found no effect of health on BMI change, and 
found, instead, that falling BMI tends to precede health 
decline.13 Prospective studies of weight loss and physical 
function or mobility yield conflicting results.14,15
 In this study, we aim to clarify the relationship be-
tween disease and weight loss among longitudinal survey 
participants by testing for associations between self-re-
ported clinical diagnoses and subsequent or concurrent 
BMI loss. We use two prospective, population-based 
surveys, one based in Costa Rica and one in England. 
These countries have very different socioeconomic and 
public health histories, but, in 2010, had roughly simi-
lar mean BMI (26.7 in Costa Rica v. 27.0 in the United 
Kingdom) and obesity prevalence (24.0 v. 25.0%).16 Both 
countries’ surveys include three waves with measured 
height and weight, whereas most previous population 
studies have relied on self-reported values for at least one 
wave. Self-reports may be biased.17 Furthermore, survey 
respondents may be unlikely to know and report their 
true weight if weight is changing rapidly. Using objective 
weight measurements, this study allows a more robust 
investigation of disease and weight loss in non-clinical 
samples than has previously been possible. 
Materials and methods
Data
Data come from two longitudinal surveys: the Costa 
Rican Longevity and Healthy Aging Study (CRELES) 
and the English Longitudinal Study of Ageing (ELSA). 
Data collection, including sampling scheme and mea-
surement of height and weight, has been described 
elsewhere.18,19 Each survey is nationally representative, 
within certain age limits, of the population from which it 
is drawn. Each measures participants’ height (by stadi-
ometer) and weight (by scale) over at least three waves, 
and each collects detailed reports about health history 
and recent diagnoses. Because relationships between 
BMI and health may vary by age, especially among 
the very elderly,20 we limit the sample to participants 
below age 80. The age range for the CRELES sample is 
61-79. The age range for the ELSA sample is 52-79. By 
studying two culturally distinct populations, we hope 
to assess the constancy of relationships across samples.
Survey waves. Table I shows measurement timing. For 
simplicity, we refer to waves with initial height and 
weight measurements as time 1; waves with the second 
measurements as time 2, and waves with the third as time 
3, although these times do not occur in the same years 
in ELSA as in CRELES. In CRELES, measurements oc-
curred roughly biennially around 2005, 2007, and 2009. 
Table I
MeasureMent in Costa riCa (CreLes)
and in engLand (eLsa), 2001-2009
CRELES ELSA
Year	of	first	BMI	measurement	(time 1) 2004-2006 2001
Year	of	second	BMI	measurement	(time 2) 2006-2008 2004-2005
Year	of	third	BMI	measurement	(time 3) 2009-2010 2008-2009
Length	of	interval	between	BMI	measurements 1.5-2.5 years 3-4 years
Age	range	(at	the	end	of	each	interval) 61-79 52-79
Sample	size	(observed	at	two	adjacent	times) 1	285 4 423
CRELES:	Costa	Rica	Longevity	and	Health	Aging	Study
ELSA:	English	Longitudinal	Study	of	Ageing
Artículo originAl
314 salud pública de méxico / vol. 57, no. 4, julio-agosto de 2015
Blue L y col.
In ELSA, measurements occurred first in 1998-1999 or 
2001 (because ELSA’s first wave was split), and then in 
2004-2005 and 2008-2009. To ensure comparable BMI-
change measurements, we restrict the CRELES sample 
to include BMI observations spaced at least 18 months 
and no more than 30 months apart. We restrict the ELSA 
sample to include observations three to four years apart 
(effectively removing any initial BMI measurement 
before 2001). Thus intervals between measurements are 
about the same length within each study population, 
but are shorter in CRELES than ELSA. This prevents 
direct comparison between countries of the magnitude 
of associations. We may still compare across them for 
evidence of any association—but differences could re-
flect variations either in the underlying relationships or 
in study limitations (e.g., in statistical power).
Definition of “weight loss”. We calculate BMI at each wave, 
and define two (overlapping) categories of weight loss: 
a) measured BMI loss between two adjacent survey 
waves of >1.0 BMI point, and b) measured BMI loss 
between adjacent survey waves of >2.0 BMI points. We 
define weight loss using categorical variables because 
many diseases are more common among both weight 
losers and weight gainers (results not shown). It is plau-
sible, therefore, that some diseases are associated with 
weight loss beyond a given threshold, but not with mean 
weight change (see Sensitivity analysis below, for discus-
sion of additional analyses with continuous outcomes).
 All height and weight values come from direct 
measurement rather than self-reports. We discarded 
outlier observations with height <1.22 m or >2.03 m, 
weight <31.8 kg, or a recorded height change >10 cm 
between waves—restrictions that eliminate roughly 
0.2% of the sample from CRELES and 0.1% from ELSA. 
In both samples, BMI change is driven overwhelmingly 
by weight change, as participants’ heights fluctuate only 
slightly between waves.
 Within each population, we assume the relationship 
between disease and weight loss from time 1 to 2 is the 
same as from time 2 to 3. Analysis of each period sepa-
rately supports this view (results not shown). Because 
simple random- and fixed-effects models do not fit the 
data well (an individual’s weight-change observations 
tend to be negatively correlated), we include only one 
period per participant. For participants observed at all 
three waves, we use the weight-change observation from 
time 1 to 2. 
Disease diagnoses. CRELES and ELSA participants report 
lifetime and recent disease diagnoses at time 1, and all 
new diagnoses since the previous interview at times 2 and 
3. We focus on six major conditions: cancer, diabetes, heart 
attack, stroke, arthritis, and lung disease. We consider a 
condition present “at baseline” if a respondent reports the 
diagnosis (occurring in the past two years for cancer, or 
ever diagnosed for other conditions) in the wave starting 
the weight-change interval. We consider “disease onset” 
to occur if the respondent does not report the disease at 
the initial wave, but reports it at the next wave. 
 Disease definitions are the same in CRELES and 
ELSA for three of the six conditions, but three definitions 
are different. Diabetes status in ELSA is determined by 
self-report, whereas in CRELES it is determined in part 
by fasting glucose and glycosylated hemoglobin tests 
administered by CRELES; this broader definition may 
capture less severe cases than those identified in ELSA. 
In ELSA, study participants are asked if a doctor has 
ever diagnosed “chronic lung disease such as chronic 
bronchitis or emphysema”; in CRELES, the lung-disease 
question adds asthma and tuberculosis. Finally, in 
CRELES, questions about heart attack are specific to that 
event, whereas ELSA combines three serious manifesta-
tions of cardiovascular disease—heart attack, angina, 
and congestive heart failure—into a single marker that 
we label “heart attack”.
Survey attrition and eligible sample. As noted above, the 
sample is the subset of CRELES and ELSA respondents 
with BMI measurements at two adjacent waves. Because 
attrition is likely correlated with disease, this study does 
not describe the typical magnitude or prevalence of 
illness-induced weight loss within a population. Instead, 
we examine associations between disease and weight 
loss over 1.5 to 4 years among a group with continued 
participation in voluntary, longitudinal surveys—simi-
lar to those used for many epidemiological studies. Re-
sults are not generalizable to the full population. 
 In each country, 3 to 5% of participants die between 
any two waves. Loss to follow-up among survivors 
ranges from just under 10% (between times 1 and 2 in 
CRELES) to roughly one third (between ELSA’s first 
wave and the first follow-up).
Regression analyses. In four separate logistic regression 
analyses—one for each weight-loss outcome in each 
country—we estimate associations between diseases 
and weight loss, adjusting for age, sex, smoking status 
(current, former, never, measured at the start of the 
weight-change interval), and initial BMI. In each model, 
we include variables for each disease at baseline and 
each new diagnosis during the measurement interval. 
All analyses are performed in Stata 12 (StataCorp LP, Col-
lege Station, TX). We do not use sample weights because 
weights in CRELES and ELSA were not designed for the 
present sample (participants with repeated BMI measure-
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ments), and because there is no consensus on whether to 
include survey weights in regression analyses.21
 Odds ratios associated with continuous variables 
(i.e., age, BMI) are calculated for a two-standard-deviation 
change (approximately), as this makes the magnitude 
of estimates from continuous variables comparable to 
those from binary variables, at least when the mean of the 
binary variable is close to 0.5.22 Confidence intervals may 
be used to test whether any given odds ratio is different 
from 1.0. However, due to the large number of parameters 
tested (68, excluding sensitivity analysis), we expect to 
find roughly three associations significant at 5% if there 
are no true relationships. Each association, taken alone, 
should therefore be viewed as suggestive. 
Sensitivity analysis. We test several alternative model 
specifications. First, we examine how results change 
with different predictor (i.e., disease) variables, includ-
ing composite measures of disease and participants’ 
self-rated overall health (details available upon request). 
Next, we examine how results change with a different 
functional form: namely, linear regression using a con-
tinuous outcome (either weight change in kilograms, or 
BMI change in points). 
Results
Close to 20% of individuals in each sample have weight 
loss >1.0 BMI point and 6 to 8% have loss >2.0 points 
(table II). Mean BMI change is close to zero in both 
samples as weight gain is about as common as loss. 
Results are for the study samples only, not the national 
populations from which they were drawn, as we have 
no appropriate survey weights.
 The proportions with self-reported disease at base-
line range from less than 3% (for stroke or cancer) to 
24% (for diabetes in CRELES and arthritis in ELSA). In 
both samples, the proportion with disease onset is less 
than 5% for all diseases, except arthritis in ELSA (12%). 
In CRELES (N=1 285), these low proportions result in 
poor statistical power to detect relationships between 
disease and weight loss—less than 50% power to reject 
the null for three quarters of the tests, assuming the true 
odds ratio is 2. This means we are unlikely to observe 
Table II
BMi Changes Between adjaCent waves of a LongitudinaL survey:* saMpLe CharaCteristiCs  
in CreLes (Costa riCa) and eLsa (engLand), 2001-2009, with 95% ConfidenCe intervaLs
CRELES ELSA
Mean	BMI	change	(in	BMI	points) -0.02  [-0.10-0.06]
0.20  
[0.14-0.25]
Proportion	with	BMI	loss	>1.0	point 18.5%	 [16.4-20.6]
19.8%	 
[18.6-21.0]
Proportion	with	BMI	loss	>2.0	points 5.6%	 [4.3-6.9]
8.4%	 
[7.6-9.3]
Proportion	reporting	each	disease	(Baseline	/	Onset)
						Cancer 1.1%	/	1.1%	 [0.5-1.7]	/	[0.5-1.7]
2.5%	/	1.8%	 
[2.0-2.9]	/	[1.4-2.2]
      Diabetes 23.9%	/	4.3%	 [21.6-26.3]	/	[3.2-5.4]
6.0%	/	2.5% 
[5.3-6.7]	/	[2.0-2.9]
      Heart attack 4.1%	/	1.2%	 [3.0-5.2]	/	[0.6-1.8]
5.6%	/	3.8%	 
[4.9-6.3]	/	[3.2-4.3]
						Stroke 2.7%	/	0.5%	 [1.8-3.6]	/	[0.1-0.9]
0.9%	/	0.9%	 
[0.6-1.1]	/	[0.6-1.2]
						Arthritis 14.6%	/	3.1% [12.7-16.6]	/	[2.0-4.1]
24.0%	/	11.7%	 
[22.7-25.3]	/	[10.8-12.7]
						Lung	disease 16.1%	/2.0%	 [14.1-18.1]	/	[1.3-2.8]
2.4%	/	2.6% 
[2.0-2.9]	/	[2.1-3.0]
*	Outcomes	from	Costa	Rica	represent	values	observed	between	CRELES	waves	in	2005	and	2007,	or	between	waves	in	2007	and	2009.	Values	from	England	
are	those	observed	between	ELSA	waves	in	2001	and	2004-2005,	or	between	2004-2005	and	2008-2009
CRELES:	Costa	Rica	Longevity	and	Health	Aging	Study
ELSA:	English	Longitudinal	Study	of	Ageing
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associations in CRELES because disease itself, especially 
new disease onset between waves (two years apart), is 
relatively rare. This fact alone is informative, suggest-
ing that the impact of observed disease on weight loss 
is unlikely to be substantial. In ELSA, power is greater 
than 70% for nearly two-thirds of the statistical tests, 
and greater than 90% for one-third. 
 Figure 1 shows odds ratios from logistic regression 
of BMI loss >1.0 point on self-reported diseases, adjusted 
for age, sex, smoking status, and starting BMI. Figure 2 
shows results from the analyses of BMI loss >2.0 points. 
In figure 1, we observe associations between diabetes in 
ELSA and BMI loss >1.0 point (OR=1.63 for diabetes at 
baseline [95%CI: 1.23-2.17], and OR=1.94 for onset dur-
ing the weight-change interval [95%CI: 1.29-2.93]). No 
other conditions are associated at 5% in either country. 
In figure 2, however, where the outcome is weight loss 
>2.0 BMI points, associations with diabetes in England 
appear stronger (OR=2.08 for disease at baseline [95%CI: 
1.45-2.99], and OR=2.25 for onset [95%CI: 1.34-3.80]). We 
further observe associations in England between cancer 
onset and weight loss (OR=2.70 [95%CI: 1.49-4.89]) and 
between lung disease onset and weight loss (OR=1.82 
[95%CI: 1.02-3.26]). In Costa Rica, no reports of new dis-
ease onset are significantly associated with weight loss, 
but we find a relationship between baseline arthritis and 
weight loss >2.0 BMI points (OR=2.00 [95%CI: 1.08-3.72]).
 Results are similar when we estimate associations 
between weight loss and disease composite variables or 
self-reported health (results from sensitivity analysis are 
not shown). Similarly, we find no new associations with 
disease when we define weight change as a continuous 
variable, modeling associations using linear regression 
(results not shown). Sensitivity analysis results are avail-
able on request. 
Discussion
This study is among the first to examine disease char-
acteristics of people losing weight in population-based, 
prospective data. We analyze two surveys, in two coun-
tries, each collecting measured height and weight and 
detailed self-reports of clinical diagnoses.
 Although some diseases cause weight loss,9,10 we 
find that associations between disease and weight loss 
among population-based survey participants vary con-
siderably, both by survey and by magnitude of weight 
loss considered. We find more apparent relationships in 
ELSA than CRELES, and more apparent relationships 
with BMI loss >2.0 points than BMI loss >1.0 point. 
The larger number of significant associations between 
disease and major weight loss may suggest that mild 
loss has many causes (including, e.g., improved diet 
and exercise), while people with major weight loss 
are unusually likely to be sick. Observed variation by 
country could reflect differences in the burden of disease 
(e.g., in prevalence of different conditions, or in typical 
disease severity), differences in diagnosis norms or 
reporting, or simply different survey sampling (e.g., 
in age range covered, sample size and hence power, or 
intervals between BMI measurements). Together, the 
results provide equivocal support for the hypothesis that 
disease drives weight loss in population-based surveys. 
They further demonstrate that relationships may not be 
constant across populations. This, in turn, suggests that 
BMI may be difficult to interpret as a causal exposure in 
epidemiological research—because the effect of disease 
on BMI may vary across samples.
 Our findings are largely exploratory, as we test for 
many possible associations in two different countries. 
This strategy is motivated by a lack of theoretical or 
empirical work to inform decisions about modeling 
disease and weight loss. However, because we find the 
strongest associations between disease and extreme 
weight loss, future scholars may wish to test for relation-
ships between health and weight change at the left tails 
of the weight-change distribution.
 This study has four limitations that prevent us from 
interpreting results—for people with BMI measurements 
in adjacent waves of a longitudinal survey—as evidence 
of causal effects of disease on weight loss. First, despite 
relatively high-quality data, measurements of weight 
change and disease onset remain crude because we ob-
serve people only periodically. Thus we observe net BMI 
change, rather than all BMI changes, between the waves. 
Furthermore, we do not observe the exact sequence 
of disease and weight-change events. When disease is 
diagnosed between survey waves, we cannot determine 
whether disease precedes or follows weight change.
 Second, diagnoses are self-reported. Self-reports 
may be inaccurate, either because participants do not 
know they are sick, do not know the name of the disease 
that affects them, or choose not to report their illness 
in a survey. Reporting norms may vary across the two 
countries. Each disease-diagnosis category may also 
represent a broad range of disease severity.
 Third, as noted above, we may lack statistical power 
to detect relationships, especially in CRELES. With few 
people in this sample experiencing new disease onset, 
in particular, we are unlikely to observe associations 
between disease onset and weight loss.
 Fourth, we observe weight change only among 
survey participants who survive and have BMI mea-
sured in adjacent survey waves. In the absence of survey 
attrition, associations between disease and weight loss 
would likely be larger than observed here, since survey 
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*	 BMI	loss	values	from	Costa	Rica	represent	net	losses	between	CRELES	waves	in	2005	and	2007,	or	between	waves	in	2007	and	2009.	Values	from	England	
represent	net	losses	between	ELSA	waves	in	2001	and	2004-2005,	or	between	2004-2005	and	2008-2009
CRELES:	Costa	Rica	Longevity	and	Health	Aging	Study
ELSA:	English	Longitudinal	Study	of	Ageing
figure 1. seLf-reported disease and BMi Loss >1.0 BMi point in CreLes (Costa riCa) and eLsa 
(engLand)* 2001-2009
Odds ratios, with 95% confidence intervals, predicting BMI loss >1.0 point
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New lung disease by interval end
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*	BMI	loss	values	from	Costa	Rica	represent	net	losses	between	CRELES	waves	in	2005	and	2007,	or	between	waves	in	2007	and	2009.	Values	from	England	
represent	net	losses	between	ELSA	waves	in	2001	and	2004-2005,	or	between	2004-2005	and	2008-2009
‡	No	CRELES	participant	experiences	new	stroke	onset	and	BMI	loss	>2.0	BMI	points
CRELES:	Costa	Rica	Longevity	and	Health	Aging	Study
ELSA:	English	Longitudinal	Study	of	Ageing
figure 2. seLf-reported disease and BMi Loss >2.0 BMi points in CreLes (Costa riCa) and eLsa 
(engLand)* 2001-2009
3.38
0.92
3.61
0.77
1.03
2.00
1.06
0.66
1.74
0.90
3.87
1.40
See note‡
2.00
0.97
1.45
1.18
2.70
0.71
2.50
1.28
1.67
1.15
1.34
2.08
2.25
0.80
1.22
0.46
1.44
1.21
0.99
1.31
1.82
0.1 1 10 0.1 1 10
Odds ratios, with 95% confidence intervals, predicting BMI loss >2.0 point
CRELES ELSA
Age at interval start (per 10-year change)
Female sex
Current smoker at interval start
Former smoker at interval start
BMI at interval start (per 10-point change)
Cancer at interval start
New cancer by interval end
Diabetes at interval start
New diabetes by interval end
Heart disease at interval start
New heart disease by interval end
Stroke by interval start
New stroke by interval end
Arthritis at interval start
New arthritis by interval end
Lung disease at interval start
New lung disease by interval end
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exit and death are very likely correlated with sickness, 
and death is very likely correlated with weight loss, as 
in other populations.1-3
 Despite these limitations to generalizability, we 
believe our findings provide valuable information 
about the disease determinants of weight loss among 
middle-aged and older Costa Rican and English adults, 
who participate in two adjacent waves of longitudinal, 
population-based surveys. These surveys are similar 
to many others used in observational epidemiology, 
but include superior data on weight change over time. 
Epidemiologists should be aware that typical BMI data 
may reflect both the effects of body weight on health, 
and of health on body weight—but that processes could 
vary from one sample to the next, complicating causal 
interpretation. Our findings suggest both that one-time 
BMI measurements are noisy measures of long-term BMI 
exposure (because weight change is relatively common), 
and that the impact of health on BMI is complex. 
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